Phase III randomized trial of adjuvant chemotherapy with or without bevacizumab for patients with completely resected stage IB (> 4cm)-IIIA non-small lung cancer (NSCLC)

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrials.gov/ct2/show/NCT00324805?term=NCT00324805&rank=1

2. Intervention

   Bevacizumab

3. Additional Topic(s)

   Combined antineoplastic chemotherapy

4. Resource Description

   Giving chemotherapy together with bevacizumab after surgery may kill any tumor cells that remain after surgery. This randomized phase III trial is studying chemotherapy and bevacizumab to see how well they work compared to chemotherapy alone in treating patients with stage IB, stage II, or stage IIIA non-small cell lung cancer that was removed by surgery.

5. Contact

   Berenberg, Jeffrey

6. PI

   Berenberg, Jeffrey

7. Topic

   non-small cell lung carcinoma

8. Study Population

   Males and females at least 18 years old who have undergone surgery to completely remove the tumor within the past 6-12 weeks and who are 5 years past hormone or radiation therapy for cancer.

9. Website(s)

   http://www.cancer.gov/clinicaltrials/featured/trials/ecog-e1506

10. Website(s)

    http://www.cancer.gov/clinicaltrials/search/view?cdrid=475774&version=healthprofessional

11. Funded by

    Cancer Trials Support Unit

12. Phase

    Phase 3 clinical trial

13. Performed by

    Clinical Protocol & Data Management Shared Resource